Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma

American Journal of Medical Genetics

Volumn 92, Issue 2, 2000, Pages 136-141

  Tachibana, Issei ^a   Smith, Justin S ^a   Sato, Kazunari ^a   Hosek, Sandra M ^a   Kimmel, David W ^a   Jenkins, Robert B ^a  

^a MAYO CLINIC   (United States)

Author keywords

Familial glioma; Melanoma; Tumor suppressor gene

Indexed keywords

DNA; PROTEIN P16;

ADULT; ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; FAMILIAL DISEASE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC PREDISPOSITION; GLIOMA; HUMAN; MALE; MELANOMA; POINT MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BRAIN NEOPLASMS; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; DNA; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENES, P53; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; GLIOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PHOSPHORIC MONOESTER HYDROLASES; PROTEINS; PROTO-ONCOGENE PROTEINS; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEINS;

BIKINIA LE-TESTUI;

EID: 0034658238     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(20000515)92:2<136::AID-AJMG11>3.0.CO;2-S     Document Type: Article

References (46)

1. Acqui M, Ferrante R, Vagnozzi R, Mastronardi L, Fortuna A. 1989. Occasionally-occurring familial brain tumors (OFBT). J Neurosurg Sci 33: 263-269.
2. Bahuau M, Vidaud D, Jenkins RB, Bieche I, Kimmel DW, Assouline B, Smith JS, Alderete B, Cayuela JM, Harpey JP, Caille B, Vidaud M. 1998. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 58:2298-2303.
3. Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, McWhorter WP, Skolnick MH. 1994. Familiality of cancer in Utah. Cancer Res 54:2378-2385.
4. Chung R, Whaley J, Kley N, Anderson K, Louis D, Menon A, Hettlich C, Freiman R, Hedley-White ET, Martuza R, Jenkins R, Yandell D, Seizinger BR. 1991. TP53 gene mutations and 17p deletions in human astrocytomas. Genes Chromosomes Cancer 3:323-331.
5. FitzGerald MG, Harkin DP, Silva-Arrieta S, MacDonald DJ, Lucchina LC, Unsal H, O'Neil E, Koh J, Finkelstein DM, Isselbacher KJ, Sober AJ, Haber DA. 1996. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci USA 93:8541-8545.
6. Furnari FB, Huang HJS, Cavenee WK. 1998. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 58:5002-5008.
7. INK4B in families with glioma. Clin Cancer Res 3: 977-981.
8. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF Jr, Li FP. 1991. Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 51:6094-6097.
9. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
10. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B, Burger PC, Wood PA, Taqi F, Booker SV, Petersen GM, Offerhaus GJS, Tersmette AC, Giardiello FM, Vogelstein B, Kinzler KW. 1995. The molecular basis of Turcot syndrome. N Engl J Med 332:839-847.
11. INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of CDK4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res 55:4833-4836.
12. Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP. 1998. Multiple primary cancers in families with Li-Fraumeni. J Natl Cancer Inst 90: 606-611.
13. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH, Jr, Tucker MA, Dracopoli NC. 1994. Germline p16 mutations in familial melanoma. Nat Genet 8:15-21.
14. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, 3rd, Johnson BE, Skolnick MH. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
15. Kamb A. 1995. Cell-cycle regulators and cancer. Trends Genet 11:136-140.
16. Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ. 1999. Tumor spectrum in ARF-deficient mice. Cancer Res 59:2217-2222.
17. Kaufman DK, Kimmel DW, Parisi JE, Michels W. 1993. A familial syndrome with cutaneous malignant melanoma and cerebral astrocytoma. Neurology 43:1728-1731.
18. Kleihues P, Cavenee WK. 1997. Pathology and genetics of tumors of the nervous system. Lyon, France: International Agency for Research on Cancer.
19. Kleihues P, Schäuble B, zur Hausen A, Esteve J, Ohgaki H. 1997. Tumors associated with p53 germline mutations. A synopsis of 91 families. Am J Pathol 150:1-13.
20. Laugé A, Lefebvre C, Laurent-Puig P, Caux V, Gad S, Eng C, Longy M, Stoppa-Lyonnet D. 1999. No evidence for germline PTEN mutations in families with breast and brain tumors. Int J Cancer 84:216-219.
21. Li FP, Fraumeni JF, Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW. 1988. A cancer family syndrome in 24 kindreds. Cancer Res 48:5358-5362.
22. Li YJ, Sanson M, Hoang-Xuan K, Delattre JY, Poisson M, Thomas G, Hamelin R. 1995. Incidence of germ-line p53 mutations in patients with gliomas. Int J Cancer 64:383-387.
23. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1946.
24. Liaw D, Marsh DJ, Li J, Dahia PH, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R. 1997. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet 16:64-67.
25. Liu W, James CD, Frederick L, Alderete BE, Jenkins RB. 1997. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 57:5254-5257.
26. Louis DN. 1997. A molecular genetic model of astrocytoma histopathology. Brain Pathol 7:755-764.
27. Malkin D. 1994. Germ-line p53 mutations and heritable cancer. Annu Rev Genet 28:443-465.
28. Marsh DJ, Dahia PLM, Zheng Z, Liaw D, Parsons R, Gorlin RJ, Eng C. 1997. Germ-line mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16:333-334.
29. Olschwang S, Serova-Sinilnikova OM, Lenoir GM, Thomas G. 1998. PTEN germ-line mutations m juvenile polyposis coli. Nat Genet 18:12-14.
30. Perry A, Nobori T, Ru N, Anderl K, Borell TJ, Mohapatra G, Feuerstein BG, Jenkins RB, Carson DA. 1997. Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR. J Neuropathol Exp Neurol 56:999-1008.
31. Platz A, Hansson J, Månsson-Brahme E, Lagerlof B, Linder S, Lundqvist E, Sevigny P, Inganas M, Ringborg U. 1997. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J Natl Cancer Inst 89:697-702.
32. Rasheed BKA, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH. 1994. Alterations of the TP53 gene in human gliomas. Cancer Res 54:1324-1330.
33. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldrige R, Aurias A, Delattre O, Thomas G. 1993. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature (London) 363:515-521.
34. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB. 2000. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocvtomas, and mixed oligoastrocytomas. J Clin Oncol 18:636-645.
35. Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, Benard J, Bressac-de Paillerets B. 1998. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. Hum Mol Genet 7:209-216.
36. Steck PA, Perhouse MA, Jasser SA, Yunk WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362.
37. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. 1998. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614-1617.
38. The European Chromosome 16 Tuberous Sclerosis Consortium. 1993. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 75:1305-1315.
39. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. 1996. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56:150-153.
40. van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG. 1994. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J Natl Cancer Inst 86:1011-1017.
41. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JBM, Ward S, Green AJ, Yates JRW, Kwiatowski J, Henske EP, Short MP, Haines JH, Jozwiak S. Kwiatowski DJ. 1997. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805-808.
42. Varmus H, Weinberg RA. 1993. Genes and the biology of cancer. New York: Scientific American Library.
43. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Bereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS. 1990. Type I neurofibromatosis gene: identification of a large transcript disrupted in three NFl patients. Science 249:181-186.
44. Wrensch M, Lee M, Miike R, Newman B, Barger G, Davis R, Wiencke J, Neuhaus J. 1997. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 145:581-593.
45. Zariwala M, Schmid S, Pfaltz M, Ohgaki H, Kleihues P, Schafer R. 1994. p53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumors and lymph-node metastases. Int J Cancer 56:807-811.
46. INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12:97-99.